Retatrutide 40mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided.

For research use only – not for human or veterinary use.

Product Overview
Retatrutide is a tri-agonist research peptide studied for its relevance to GLP GIP and glucagon-related biochemical pathways. This lyophilized 40 mg preparation supports controlled laboratory evaluation of purity identity and receptor-modulation behaviour across multi-pathway metabolic models.

Peptide Overview
Between 2018 and 2025 Retatrutide became a major focus within metabolic-regulation research due to its multi-receptor signalling profile and biochemical stability. Its defined analytical characteristics allow reproducible in-vitro evaluation of complex metabolic-response pathways.

Historical Background and Scientific Context
From 2020 onward tri-agonist peptides such as Retatrutide were increasingly studied for their potential in multi-pathway metabolic modelling. Research groups explored its receptor synergy and its ability to engage GLP GIP and glucagon pathways simultaneously, supporting advanced biochemical and metabolic-turnover analysis.

Mechanistic Focus in Research

• Multi-receptor metabolic-pathway modelling involving GLP GIP and glucagon
• In-vitro receptor-synergy and pathway-integration studies
• Comparative tri-agonist peptide analysis
• Biochemical modelling of energy-regulation mechanisms
• Controlled multi-pathway receptor-modulation experiments

Analytical Verification (COA)
Independent Liquilabs analysis confirms full analytical validation for Batch GF102025047. Key results include:

• Assay Content: 41.66 mg
• Identification – Retention Time: 1.00
• Identification – Spectrum: 999
• Purity: 99.7 percent
• Endotoxins: below 0.001 EU per mg
• Microbial Growth: not detected for aerobic count yeast or mold
• Heavy Metals: not detected including arsenic cadmium cobalt lead nickel mercury vanadium

All analytical values were obtained using validated chromatographic spectroscopic and microbiological procedures ensuring transparency and full traceability.

Research Applications

• Metabolic-signalling and multi-agonist pathway modelling
• Receptor-integration and comparative energy-regulation studies
• Biochemical modelling of GLP GIP and glucagon pathways
• In-vitro multi-pathway modulation experiments
• Advanced metabolic-response pathway analysis

Grail Formula Quality
Every Grail Formula research peptide undergoes independent laboratory verification for purity identity structural integrity and microbial safety. All batches are validated for stability and reproducibility to support consistent scientific outcomes.

When You Choose Grail Formula…
Researchers receive fully documented peptides with batch-number traceability sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

For research use only – not for human or veterinary use.

• Verified and analysed with Liquilabs s.r.o. Czechia
• 99.7 percent purity with validated assay content
• No detectable heavy metals or microbial contamination
• Endotoxin below 0.001 EU per mg
• Batch GF102025047 – Published November 2025
• EU shipments include bacteriostatic water
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.